PH24934A - Medicaments for the treatment of addition - Google Patents
Medicaments for the treatment of additionInfo
- Publication number
- PH24934A PH24934A PH36099A PH36099A PH24934A PH 24934 A PH24934 A PH 24934A PH 36099 A PH36099 A PH 36099A PH 36099 A PH36099 A PH 36099A PH 24934 A PH24934 A PH 24934A
- Authority
- PH
- Philippines
- Prior art keywords
- methyl
- medicaments
- treatment
- addition
- abuse
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 abstract 2
- -1 2-methyl-1H-imidazol-1-yl Chemical group 0.000 abstract 1
- 206010012335 Dependence Diseases 0.000 abstract 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
- 206010048010 Withdrawal syndrome Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868627909A GB8627909D0 (en) | 1986-11-21 | 1986-11-21 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH24934A true PH24934A (en) | 1990-12-26 |
Family
ID=10607734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH36099A PH24934A (en) | 1986-11-21 | 1987-11-20 | Medicaments for the treatment of addition |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4847281A (enExample) |
| EP (1) | EP0278161B1 (enExample) |
| JP (1) | JPH0830008B2 (enExample) |
| KR (1) | KR950010148B1 (enExample) |
| AT (1) | ATE74271T1 (enExample) |
| AU (1) | AU608788B2 (enExample) |
| CY (1) | CY1694A (enExample) |
| DE (1) | DE3778008D1 (enExample) |
| DK (1) | DK612787A (enExample) |
| ES (1) | ES2033879T3 (enExample) |
| GB (1) | GB8627909D0 (enExample) |
| GR (1) | GR3004252T3 (enExample) |
| HK (1) | HK36793A (enExample) |
| IE (1) | IE61033B1 (enExample) |
| PH (1) | PH24934A (enExample) |
| ZA (1) | ZA878702B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4948803A (en) * | 1986-11-21 | 1990-08-14 | Glaxo Group Limited | Medicaments for treatment on prevention of withdrawal syndrome |
| US5198447A (en) * | 1986-11-21 | 1993-03-30 | Glaxo Group Limited | Medicaments |
| DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
| US5272168A (en) * | 1987-07-11 | 1993-12-21 | Sandoz Ltd. | Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
| US5198459A (en) * | 1987-07-11 | 1993-03-30 | Sandoz Ltd. | Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
| GB8820650D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
| US5292752A (en) * | 1989-12-21 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Antithrombotic compounds |
| US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
| US5397782A (en) * | 1990-06-13 | 1995-03-14 | Janssen Pharmaceutica N.V. | Method of treating addiction to alcohol |
| JPH06508836A (ja) * | 1991-06-26 | 1994-10-06 | セプラコア，インコーポレーテッド | 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物 |
| GB9310756D0 (en) * | 1993-05-25 | 1993-07-14 | Glaxo Lab Sa | Compositions |
| US5726644A (en) * | 1995-06-30 | 1998-03-10 | Philips Electronics North America Corporation | Lighting control system with packet hopping communication |
| US5824684A (en) * | 1997-02-21 | 1998-10-20 | Synapse Pharmaceuticals International, Inc. | Method for treating drug and alcohol addiction |
| US20080004260A1 (en) * | 2006-06-29 | 2008-01-03 | Transcept Pharmaceuticals, Inc. | Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
| US9226918B2 (en) * | 2008-12-04 | 2016-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating or preventing narcotic withdrawal symptoms |
| US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
| US20110288115A1 (en) * | 2010-05-24 | 2011-11-24 | Avmedis Llc | Treatment of vagally-mediated spectrum disorders |
| WO2021127391A1 (en) | 2019-12-20 | 2021-06-24 | The Jackson Laboratory | Molecular targets for addiction |
| EP4673443A1 (en) * | 2023-03-01 | 2026-01-07 | The Jackson Laboratory | Methods and compositions for treating cocaine addiction |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4499096A (en) * | 1983-11-18 | 1985-02-12 | Lotsof Howard S | Rapid method for interrupting the narcotic addiction syndrome |
| SE460359B (sv) * | 1984-01-25 | 1989-10-02 | Glaxo Group Ltd | 3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition |
| EP0201165B1 (en) * | 1985-03-14 | 1994-07-20 | Beecham Group Plc | Medicaments for the treatment of emesis |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
| DE3780276T2 (de) * | 1986-12-16 | 1993-02-25 | Robins Co Inc A H | Angstloesende n-(1-azabicyclo(2.2.2)oct-3-yl)benzamide und -thiobenzamide. |
| DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
-
1986
- 1986-11-21 GB GB868627909A patent/GB8627909D0/en active Pending
-
1987
- 1987-11-20 JP JP62293894A patent/JPH0830008B2/ja not_active Expired - Lifetime
- 1987-11-20 AT AT87310289T patent/ATE74271T1/de not_active IP Right Cessation
- 1987-11-20 IE IE315687A patent/IE61033B1/en not_active IP Right Cessation
- 1987-11-20 DK DK612787A patent/DK612787A/da not_active Application Discontinuation
- 1987-11-20 AU AU81443/87A patent/AU608788B2/en not_active Ceased
- 1987-11-20 PH PH36099A patent/PH24934A/en unknown
- 1987-11-20 ES ES87310289T patent/ES2033879T3/es not_active Expired - Lifetime
- 1987-11-20 KR KR1019870013069A patent/KR950010148B1/ko not_active Expired - Fee Related
- 1987-11-20 EP EP87310289A patent/EP0278161B1/en not_active Expired - Lifetime
- 1987-11-20 DE DE8787310289T patent/DE3778008D1/de not_active Expired - Lifetime
- 1987-11-20 ZA ZA878702A patent/ZA878702B/xx unknown
- 1987-11-20 US US07/123,369 patent/US4847281A/en not_active Expired - Lifetime
-
1992
- 1992-04-02 GR GR920400436T patent/GR3004252T3/el unknown
-
1993
- 1993-04-15 HK HK367/93A patent/HK36793A/en not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169494A patent/CY1694A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4847281A (en) | 1989-07-11 |
| DK612787D0 (da) | 1987-11-20 |
| IE873156L (en) | 1988-05-21 |
| ZA878702B (en) | 1988-09-28 |
| EP0278161A1 (en) | 1988-08-17 |
| AU608788B2 (en) | 1991-04-18 |
| DE3778008D1 (de) | 1992-05-07 |
| CY1694A (en) | 1994-01-14 |
| ES2033879T3 (es) | 1995-04-01 |
| JPH0830008B2 (ja) | 1996-03-27 |
| DK612787A (da) | 1988-05-22 |
| IE61033B1 (en) | 1994-09-07 |
| JPS63185927A (ja) | 1988-08-01 |
| KR950010148B1 (ko) | 1995-09-11 |
| KR880005930A (ko) | 1988-07-21 |
| GR3004252T3 (enExample) | 1993-03-31 |
| HK36793A (en) | 1993-04-23 |
| GB8627909D0 (en) | 1986-12-31 |
| EP0278161B1 (en) | 1992-04-01 |
| AU8144387A (en) | 1988-05-26 |
| ATE74271T1 (de) | 1992-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH24934A (en) | Medicaments for the treatment of addition | |
| EP1736147A3 (en) | Non-chlorofluorocarbon aerosol formulations | |
| IL116203A (en) | Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron | |
| ZA956029B (en) | Combination treatment for inhibiting bone loss | |
| GEP20022752B (en) | Valaciclovir Tablets Containing Colloidal Silicon Dioxide | |
| PL299814A1 (en) | Pharmaceutical preparation inhibiting depletion of human bone tissue | |
| FR2720002B1 (fr) | Dispositif d'incision pour l'administration dermique d'un médicament. | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| HU9603042D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration | |
| GB8630071D0 (en) | Medicaments | |
| IL108234A0 (en) | Pharmaceutical composition containing galanthamine | |
| GB2223168B (en) | Pharmaceutical composition comprising inositoltrisphosphate for the treatment of complications of diabetes | |
| HU901085D0 (en) | Process for producing substituted benzimidazole and pharmaceutical preparatives containing it | |
| RO116771B1 (ro) | Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine | |
| AU638083B2 (en) | Swallowable dosage units comprising colloidal bismuth subcitrate | |
| ZA925146B (en) | Pharmaceutical agent for treatment of withdrawal symptoms. | |
| EP0410002A4 (en) | Anti-hiv drug | |
| IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
| IL88740A (en) | Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids | |
| IE873231L (en) | Medicaments | |
| WO1986006960A3 (en) | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease | |
| EP0495226A3 (en) | 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma | |
| EP0457336A3 (en) | Use of mizoribine for the treatment or prevention of multiple sclerosis | |
| IL89654A (en) | Pharmaceutical combination compositions for treating hypertension | |
| Hynd | Treating Dyslexia: A Unique Neuropsychological Approach |